Translocation (3;21) in a patient with secondary hematological malignancy.
Aventín
A
A
Servei d'Hematologia, Hospital de Sant Pau, Barcelona, Spain.
Brunet
S
S
de Andrés
L
L
Bordes
R
R
Moltó
E
E
Domingo
A
A
Pujol-Moix
N
N
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D002891:Chromosomes, Human, Pair 21; D002893:Chromosomes, Human, Pair 3; D006390:Hemangioendothelioma / Q000188:drug therapy; D006801:Humans; D015477:Leukemia, Myelomonocytic, Chronic / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary; D012888:Skull Neoplasms / Q000188:drug therapy; D014178:Translocation, Genetic